Contents

Disclaimer

Oxford University Press makes no representation, express or implied, that the drug dosages in this book are correct. Readers must therefore always check the product information and clinical procedures with the most up to date published product information and data sheets provided by the manufacturers and the most recent codes of conduct and safety regulations. The authors and the publishers do not accept responsibility or legal liability for any errors in the text or for the misuse or misapplication of material in this work. Except where otherwise stated, drug dosages and recommendations are for the non-pregnant adult who is not breastfeeding.

Show Summary Details
Page of

Schizophrenia and paranoid disorders in late life 

Schizophrenia and paranoid disorders in late life
Chapter:
Schizophrenia and paranoid disorders in late life
Author(s):

Barton W. Palmer

, Gauri N. Savla

, and Thomas W. Meeks

DOI:
10.1093/med/9780199696758.003.0200
Page of

PRINTED FROM OXFORD MEDICINE ONLINE (www.oxfordmedicine.com). © Oxford University Press, 2016. All Rights Reserved. Under the terms of the licence agreement, an individual user may print out a PDF of a single chapter of a title in Oxford Medicine Online for personal use (for details see Privacy Policy and Legal Notice).

date: 18 August 2019

Estimates of the point-prevalence of paranoia and other psychotic symptoms among persons age ⋚ 65 years have ranged from approximately 4 per cent to 6 per cent, and may be as high as 10 per cent among those age ⋚ 85 years. Although the majority of these symptoms occur as secondary psychoses in the context of Alzheimer’s disease or related dementias, the population of people with schizophrenia is ageing along with the general ‘greying’ of the industrialized world, and mental health care for older adults with schizophrenia is expected to be an increasingly important public health concern. This chapter covers clinical features, classification systems, diagnosis and differential diagnosis, epidemiology, aetiology, course and prognosis, treatment, and management.

Access to the complete content on Oxford Medicine Online requires a subscription or purchase. Public users are able to search the site and view the abstracts for each book and chapter without a subscription.

Please subscribe or login to access full text content.

If you have purchased a print title that contains an access token, please see the token for information about how to register your code.

For questions on access or troubleshooting, please check our FAQs, and if you can't find the answer there, please contact us.